chronic granulomatous disease

Showing 1 - 25 of 38

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Subjects With Chronic Granulomatous Disease (CGD)

Recruiting
  • Chronic Granulomatous Disease
  • Specimen Donation
  • Woburn, Massachusetts
    Sanguine BioSciences, Inc.
Jun 14, 2023

Voicing My CHOiCES asTool for Advanced Care Planning in Young

Recruiting
  • HIV
  • +3 more
    • Orange, California
    • +9 more
    Jan 26, 2023

    Baby Detect : Genomic Newborn Screening

    Recruiting
    • Congenital Adrenal Hyperplasia
    • +126 more
      • Liege, Wallonia, Belgium
        CRMN, Hôpital La Citadelle
      Jan 24, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +36 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 23, 2023

      Intestinal Inflammation in People With Primary Immune

      Recruiting
      • Chronic Granulomatous Disease
      • Inflammatory Bowel Disease
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 23, 2023

        Chronic Granulomatous Disease, Inflammatory Gastrointestinal Disease, Inflammatory Skin Disease Trial run by the NIAID (XELJANZ

        Enrolling by invitation
        • Chronic Granulomatous Disease
        • +3 more
        • XELJANZ (tofacitinib)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 19, 2023

        Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)

        Recruiting
        • Chronic Granulomatous Disease
        • CGD
        • JSP191
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 5, 2023

        Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,

        Completed
        • Hemophagocytic Lymphohistiocytosis
        • +5 more
        • Hematopoietic Stem Cell Transplant
        • Birmingham, Alabama
        • +21 more
        Dec 6, 2022

        Patients Treated for Chronic Granulomatous Disease Since January

        Completed
        • Chronic Granulomatous Disease
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Nov 1, 2022

          Chronic Granulomatous Disease, Infection Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (gp91

          Recruiting
          • Chronic Granulomatous Disease
          • Infection
          • gp91 Grans
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jul 26, 2022

          Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

          Recruiting
          • Chronic Granulomatous Disease
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jul 23, 2022

          Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant

          Recruiting
          • Immune Deficiency Disorders
          • +13 more
          • Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
          • Saint Louis, Missouri
            Washington University
          Apr 25, 2022

          Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease Trial in Gainesville (Thiotepa--single daily dose,

          Recruiting
          • Bone Marrow Failure Syndrome
          • +15 more
          • Thiotepa--single daily dose
          • Thiotepa--escalated dose
          • Gainesville, Florida
            UF Health Shands Children's Hospital
          Jul 8, 2021

          Interferon-gamma 1-b on Cells of Innate Immune System:

          Completed
          • Chronic Granulomatous Disease
          • Interferon Gamma-1B
          • Aurora, Colorado
            University of Colorado Anschutz Medical Campus
          Jan 20, 2021

          Chronic Granulomatous Disease Trial in Nijmegen, Amsterdam (posaconazole (PSZ))

          Completed
          • Chronic Granulomatous Disease
          • posaconazole (PSZ)
          • Nijmegen, Gelderland, Netherlands
          • +1 more
          Nov 26, 2020

          Chronic Granulomatous Disease Trial run by the NIAID (drug, biological, radiation)

          Terminated
          • Chronic Granulomatous Disease
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Apr 30, 2020

          Chronic Granulomatous Disease Trial in Moscow (Kineret)

          Completed
          • Chronic Granulomatous Disease
          • Moscow, Russian Federation
            Dmitry Rogachev National Research Center of Pediatric Hematology
          Apr 6, 2020

          Hurler Syndrome, Fanconi Anemia, Glanzmann Thrombasthenia Trial in Atlanta (Abatacept)

          Completed
          • Hurler Syndrome
          • +14 more
          • Atlanta, Georgia
            Children's Healthcare of Atlanta
          Dec 20, 2019

          Chronic Granulomatous Disease Trial in Shanghai (Pioglitazone)

          Terminated
          • Chronic Granulomatous Disease
          • Shanghai, Shanghai, China
            Children's Hospital of Fudan University
          Oct 19, 2019

          Chronic Granulomatous Disease Trial in Seoul (VM106)

          Unknown status
          • Chronic Granulomatous Disease
          • Seoul, Korea, Republic of
            Seoul National University Hospital
          Oct 16, 2019

          Chronic Granulomatous Disease Trial in Shenzhen (Infusion of lentiviral TYF-CGD-modified autologous stem cells)

          Unknown status
          • Chronic Granulomatous Disease
          • Infusion of lentiviral TYF-CGD-modified autologous stem cells
          • Shenzhen, Guangdong, China
            Shenzhen Geno-immune Medical Institute
          Sep 18, 2019

          Chronic Granulomatous Disease Trial in Moscow (Plerixafor, Gcsf)

          Unknown status
          • Chronic Granulomatous Disease
          • Moscow, Russian Federation
            Dmitry Rogachev National Research Center of Pediatric Hematology
          Sep 16, 2019

          Chronic Granulomatous Disease Trial in Aurora (Administration of drug (Interferon-gamma 1-b) subcutaneously)

          Completed
          • Chronic Granulomatous Disease
          • Administration of drug (Interferon-gamma 1-b) subcutaneously
          • Aurora, Colorado
            University of Colorado Denver, Anschutz Medical Campus
          Feb 11, 2019

          Chronic Granulomatous Disease Trial in Houston (drug, biological, procedure)

          Completed
          • Chronic Granulomatous Disease
          • Houston, Texas
            Texas Children's Hospital
          Oct 11, 2018

          Chronic Granulomatous Disease Trial run by the NIAID (Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells)

          Terminated
          • Chronic Granulomatous Disease
          • Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Jul 3, 2018